Gene · 6241
Papers4,414
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,414
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Therapeutic mucosal vaccination of herpes simplex virus type 2 infected guinea pigs with an adenovirus-based vaccine expressing the ribonucleotide reductase 2 and glycoprotein D induces local tissue-resident CD4+ and CD8+ TRM cells associated with protection against recurrent genital herpes. | Front Immunol | 2025 | 40207227 | PubTator, text mining | PubMed |
| Biomarkers and potential function analysis of triple-negative breast cancer screening based on bioinformatics. | Cancer Biomark | 2025 | 40179432 | PubTator, text mining | PubMed |
| Breaking bottlenecks: the future of hepatocellular carcinoma clinical trials and therapeutic targets. | Hepatol Int | 2025 | 40156659 | PubTator, text mining | PubMed |
| RRM1 O-GlcNAcylation inhibition suppresses pancreatic cancer via TK1-mediated replication stress. | Cancer Gene Ther | 2025 | 40155654 | PubTator, text mining | PubMed |
| Cyclin Y interacts with Chk1 to activate RRM2/STAT3 signaling and promotes radioresistance in non-small cell lung cancer. | Int J Biol Sci | 2025 | 40083692 | PubTator, text mining | PubMed |
| CORR Insights®: CD177, MYBL2, and RRM2 Are Potential Biomarkers for Musculoskeletal Infections. | Clin Orthop Relat Res | 2025 | 40062883 | PubTator, text mining | PubMed |
| Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines. | Signal Transduct Target Ther | 2025 | 40059188 | PubTator, text mining | PubMed |
| Screening of common genomic biomarkers to explore common drugs for the treatment of pancreatic and kidney cancers with type-2 diabetes through bioinformatics analysis. | Sci Rep | 2025 | 40025145 | PubTator, text mining | PubMed |
| Potential Biomarkers and Therapeutic Targets in Hepatitis B Virus-related Acute Liver Failure: Interplay of the Ferroptosis, Autophagy and Immune Responses. | Int J Med Sci | 2025 | 39991755 | PubTator, text mining | PubMed |
| KAT7-acetylated YBX1 promotes hepatocellular carcinoma proliferation by reprogramming nucleotide metabolism. | BMC Cancer | 2025 | 39984921 | PubTator, text mining | PubMed |
| Study on the effects and mechanism of RRM2 on three gynecological malignancies. | Cell Signal | 2025 | 39965737 | PubTator, text mining | PubMed |
| Human cytomegalovirus UL82 promotes cell cycle progression of colorectal cancer by upregulating AGR2. | Commun Biol | 2025 | 39962326 | PubTator, text mining | PubMed |
| Analysis of microarray and single-cell RNA-seq identifies gene co-expression, cell-cell communication, and tumor environment associated with metabolite interconversion enzyme in prostate cancer. | Discov Oncol | 2025 | 39946051 | PubTator, text mining | PubMed |
| CD177, MYBL2, and RRM2 Are Potential Biomarkers for Musculoskeletal Infections. | Clin Orthop Relat Res | 2025 | 39915095 | PubTator, text mining | PubMed |
| Nitidine chloride inhibits the progression of hepatocellular carcinoma by suppressing IGF2BP3 and modulates metabolic pathways in an m6A-dependent manner. | Mol Med | 2025 | 39910429 | PubTator, text mining | PubMed |
| Exploring the molecular interface of gene expression dynamics and prostate cancer susceptibility in response to HBCD exposure. | Toxicol Res (Camb) | 2025 | 39906184 | PubTator, text mining | PubMed |
| Osalmid sensitizes clear cell renal cell carcinoma to navitoclax through a STAT3/BCL-XL pathway. | Cancer Lett | 2025 | 39894195 | PubTator, text mining | PubMed |
| Integrated Analysis of Proteome and Transcriptome Profiling Reveals Pan-Cancer-Associated Pathways and Molecular Biomarkers. | Mol Cell Proteomics | 2025 | 39884577 | PubTator, text mining | PubMed |
| Elucidating the role of pyrimidine metabolism in prostate cancer and its therapeutic implications. | Sci Rep | 2025 | 39814835 | PubTator, text mining | PubMed |
| WEE1 Inhibition by AZD1775 Augments Colorectal Cancer Cells Susceptibility to VE-822-induced DNA Damage and Apoptosis. | Drug Res (Stuttg) | 2025 | 39805293 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6241/papers?page=11